Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery

去唾液酸糖蛋白受体 化学 药物输送 药理学 透明质酸 靶向给药 体内 癌症研究 药品 肝细胞癌 体外 医学 生物化学 生物 肝细胞 有机化学 生物技术 解剖
作者
Yulan Li,Xiaomin Zhu,Hong Liang,Chris Orvig,Zhen‐Feng Chen
出处
期刊:Current Medicinal Chemistry [Bentham Science]
卷期号:28 (8): 1508-1534 被引量:24
标识
DOI:10.2174/0929867327666200505085756
摘要

Background: Hepatocellular carcinoma (HCC) seriously affects human health, especially, it easily develops multi-drug resistance (MDR) which results in treatment failure. There is an urgent need to develop highly effective and low-toxicity therapeutic agents to treat HCC and to overcome its MDR. Targeted drug delivery systems (DDS) for cancer therapy, including nanoparticles, lipids, micelles and liposomes, have been studied for decades. Recently, more attention has been paid to multifunctional DDS containing various ligands such as polymer moieties, targeting moieties, and acid-labile linkages. The polymer moieties such as poly(ethylene glycol) (PEG), chitosan (CTS), hyaluronic acid, pullulan, poly(ethylene oxide) (PEO), poly(propylene oxide) (PPO) protect DDS from degradation. Asialoglycoprotein receptor (ASGPR) and glycyrrhetinic acid receptor (GAR) are most often used as the targeting moieties, which are overexpressed on hepatocytes. Acid-labile linkage, catering for the pH difference between tumor cells and normal tissue, has been utilized to release drugs at tumor tissue. Objectives: This review provides a summary of the recent progress in ASGPR and GAR-mediated and/or pH-responsive HCC-targeted drug delivery. Conclusion: The multifunctional DDS may prolong systemic circulation, continuously release drugs, increase the accumulation of drugs at the targeted site, enhance the anticancer effect, and reduce side effects both in vitro and in vivo. But it is rarely used to investigate MDR of HCC; therefore, it needs to be further studied before going into clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不配.应助科研通管家采纳,获得10
刚刚
大模型应助科研通管家采纳,获得10
刚刚
bkagyin应助科研通管家采纳,获得10
刚刚
美好斓应助科研通管家采纳,获得100
刚刚
刚刚
彭于晏应助科研通管家采纳,获得10
刚刚
李爱国应助科研通管家采纳,获得10
刚刚
不配.应助科研通管家采纳,获得10
1秒前
1秒前
乐乐应助科研通管家采纳,获得20
1秒前
1秒前
1秒前
1秒前
1秒前
bkagyin应助记忆采纳,获得10
2秒前
沐舒发布了新的文献求助10
5秒前
哈尼完成签到,获得积分10
6秒前
qiu关闭了qiu文献求助
9秒前
9秒前
医学帅哥完成签到,获得积分10
9秒前
无限鲜花发布了新的文献求助10
10秒前
11秒前
SciGPT应助江上清风游采纳,获得10
11秒前
Crystal发布了新的文献求助10
12秒前
12秒前
BBL完成签到 ,获得积分10
13秒前
13秒前
14秒前
fdhineodobh花开富贵完成签到,获得积分10
14秒前
曾经的冥幽完成签到 ,获得积分10
15秒前
记忆发布了新的文献求助10
15秒前
fangjie应助zhugepengju采纳,获得10
15秒前
风过大泽发布了新的文献求助10
18秒前
科研通AI2S应助LLL采纳,获得10
19秒前
19秒前
美朵1010完成签到 ,获得积分10
20秒前
Danish发布了新的文献求助10
20秒前
无限鲜花完成签到,获得积分20
21秒前
22秒前
乐乐应助沉默冬易采纳,获得30
22秒前
高分求助中
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Ethnicities: Media, Health, and Coping 700
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 600
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3088895
求助须知:如何正确求助?哪些是违规求助? 2741067
关于积分的说明 7563024
捐赠科研通 2391205
什么是DOI,文献DOI怎么找? 1268199
科研通“疑难数据库(出版商)”最低求助积分说明 614019
版权声明 598684